IPO subscription report
Paras Healthcare Limited IPO, category-wise subscription
Final bidding figures by investor category with an arithmetic estimate of allotment odds. Share the card on WhatsApp or download it as an image.
VIA Capital • IPO subscription report
Paras Healthcare Limited
PARASHLTH • Mainboard • Final figures
Issue dates
21 Oct 2026 – 23 Oct 2026
Price band
Rs.660 to Rs.693
Lot size
—
Total subscription
1.92x
Category-wise bidding
| Category | Times subscribed | Applications |
|---|---|---|
QIB Qualified Institutional Buyers — mutual funds, insurers, banks and FPIs. | 3.09x | — |
NII (Total) All non-institutional / HNI bids above ₹2 lakh. | 0.66x | — |
Retail (RII) Individual investors applying up to ₹2 lakh. | 2.00x | — |
| Total | 1.92x | — |
Total issue size
₹1,450 Cr
Shares offered
1.21 Cr shares
Shares bid for
—
Bids received (value)
—
Day-wise subscription
| Day | QIB | NII | Retail | Total | Applications |
|---|---|---|---|---|---|
Day 1 20 Oct 2026 | — | — | — | 0.00x | — |
Day 1 21 Oct 2026 | 0.00x | 0.08x | 0.69x | 0.09x | — |
Day 2 22 Oct 2026 | 0.06x | 0.25x | 1.31x | 0.23x | — |
Day 3 23 Oct 2026 | 3.09x | 0.66x | 2.00x | 1.92x | — |
Day 4 24 Oct 2026 | 3.09x | 0.66x | 2.00x | 1.92x | — |
Captured from the exchange feed once per bidding day. Days before this report was first captured are not available.
Estimated allotment chance
Retail (1 lot)
Approx. 1 in 2
1 lot • lottery basis
sNII (₹2–10 lakh)
Full allotment likely (not oversubscribed)
1 lot • lottery basis
bNII (Above ₹10 lakh)
Full allotment likely (not oversubscribed)
1 lot • proportionate basis
Educational information only. Subscription figures are sourced from exchange public data and allotment chances are arithmetic estimates from those figures — the binding allotment is the Basis of Allotment published by the registrar. VIA Capital does not provide investment advice or allotment guarantees. Read the RHP before investing. Source: NSE public market data. Captured 24/10/2026, 12:00:07 am.
Educational content only. VIA Capital does not provide buy/sell calls, tips, or personalized advice. Always do your own research.